The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 14, 2018

Primary Completion Date

July 30, 2019

Study Completion Date

August 15, 2019

Conditions
Hemangioma
Interventions
PROCEDURE

Diode laser 980-nm

Before starting the laser session, cosmetics or makeup were removed and the skin was cleaned. The area was anesthetized by the application of as EMLA lotion (lidocaine 2.5% + prilocaine 2.5%) \[ONLY MEDICAL; CAT No. R331/72394/P001\] 20 minutes before the session. During the procedure, the laser probe was held perpendicular to the lesion and a guide beam was used to direct the application. The patient wore protective eye goggles \[CE; DIR 8001100L4\]. After the session, cool air was applied to the whole region. Each patient received a maximum of six sessions, delivered at two-week intervals. Patients reported itchiness and erythema during the session.

Trial Locations (1)

10001

Institute of Laser for Postgraduate Studies, Baghdad

All Listed Sponsors
lead

Noor Taha Ismaeel

OTHER

NCT04065217 - The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial | Biotech Hunter | Biotech Hunter